Serologic evidence of high exposure to Group B streptococci (Streptococcus agalactiae) in Mexican women of reproductive age;Exposición a Estreptococo del grupo B en mujeres mexicanas en edad reproductiva

Salud Publica de Mexico

Volumn 44, Issue 1, 2002, Pages 50-56

  Palacios Saucedo, Gerardo ^a   Caltenco Serrano, Raúl ^a   Torres López, Javier ^a   Tapia Conyer, Roberto ^b   Muñoz Hernández, Onofre ^c   Solórzano Santos, Fortino ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b Dirección General Adjunta de Epidemiología   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Group B streptococci; Mexico; Neonatal sepsis; Perinatal infections; Seroprevalence; Streptococcus agalatiae

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN PURIFICATION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HIGH RISK POPULATION; HUMAN; MEXICO; NEWBORN SEPSIS; PERINATAL INFECTION; SEROLOGY; SEROPREVALENCE; SERUM; SOCIOECONOMICS; STANDARDIZATION; STREPTOCOCCUS AGALACTIAE;

EID: 0036124477     PISSN: 00363634     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-36342002000100007     Document Type: Article

References (36)

1. Group B streptococcal infections
2. Colonization of Mexican pregnant women with group B Streptococcus
3. Diseases caused by group B Streptococcus in Mexico
4. Cervicovaginal infection with group B streptococci among pregnant Mexican women
5. Streptococcus del grupo B en la etiología de la infección neonatal
6. Decreased capacity for type specific antigen synthesis accounts for high prevalence of non-typeable strains of group B streptococci in Mexico
7. Epidemiology of Group B Streptococcus: Longitudinal observations during pregnancy
8. Functional activity of antibodies to the group B polysaccharide of Group B streptococci elicited by a polisaccharide-protein conjugate vaccine
9. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection
10. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease
11. Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis of meningitis and their mothers and from healthy pregnant women
12. Human antibody to the group-specific polysaccharide of group B Streptococcus
13. Growth and amino acid requirements of various strains of group B streptococci
14. Improvement in anthrone method for determination of carbohydrates
15. The thiobarbituric acid assay of sialic acids
16. Methods for the quantitative estimation of N-acetytneuraminic acid and their application to hydrolysates of sialomucoids
17. ELISA methodology for polysaccharide antigens: Protein coupling of polysaccharides for adsorption to plastic tubes
18. Epidemiology of group B streptococcal disease: Risk factors, prevention strategy, and vaccine development
19. Group B streptococcus
20. Factors influencing release of type III antigens by group B streptococci
21. Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci
22. Association of elevated levels of cellular lipoteichoic acid of group B streptococci with human neonatal disease
23. Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40 °C
24. Urogenital, maternal and neonatal isolates of Haemophilus influenzae: Identification of unusually virulent serologically non-typeable clone families and evidence for a new Haemophilus species
25. Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli
26. Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera
27. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III
28. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico City
29. The natural history of group B streptococcal colonization in the pregnant women and her offspring. I. Colonization studies
30. Group B streptococcal disease: Its importance in the developing world and prospect for prevention with vaccines
31. Maternal carriage of group B streptococci in developing countries
32. The role of maternal syphilis, gonorrhoea and HIV-1 infections in spontaneous abortion
33. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers
34. Identification of the high-virulence clone of group B streptococci in Mexican isolates by growth characteristics at 40 °C